Edwards Lifesciences stock holds near $88 after strong July results

Published on 09/20/2026 at 12:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Edwards Lifesciences stock closed at $88.22 on September 18, 2026. July 23 results showed $0.78 EPS and $1.74 billion revenue, with guidance for 2026 EPS at $2.95 to $3.05.

Fotorealistisches Katheterlabor mit Chirurgenteam bei minimalinvasivem Herzeingriff — Edwards Lifesciences Herzklappen-OP US28176E1082 im Katheterlabor mit Fluoroskopie-Bildschirmen und Chirurgenteam in Aktion, Illustration mit AI erstellt.

Edwards Lifesciences stock (US28176E1082) closed at USD 88.22 on September 18, 2026, with a market value of USD 50.80 billion and a 52-week range of USD 72.30 to USD 96.29. The latest earnings update on July 23, 2026, showed EPS of USD 0.78 and revenue of USD 1.74 billion.

July numbers still set the tone

On July 23, 2026, Edwards Lifesciences reported EPS of USD 0.78, ahead of the USD 0.74 consensus by USD 0.04, while revenue reached USD 1.74 billion versus USD 1.70 billion expected. The company also said quarterly revenue rose 13.6 percent year over year and net margin was 15.43 percent.

That combination matters because it gives the stock a clear earnings anchor: growth was not only stronger than expected, it came with a 15.43 percent net margin and a 13.6 percent yearly revenue increase.

Guidance and analyst view

Edwards Lifesciences set Q3 2026 guidance at EPS of USD 0.71 to USD 0.77 and FY 2026 guidance at USD 2.95 to USD 3.05 per share, according to the July 23, 2026 earnings release cited by MarketBeat. On the same page, MarketBeat said the consensus price target is USD 100.27, implying 13.7 percent upside from USD 88.22.

MarketBeat also listed 17 buy ratings and 6 hold ratings, with no sell ratings, and a PEG ratio of 2.31. For investors, that keeps valuation in view even after the July beat.

Stock stays below the high

On September 18, 2026, the shares closed at USD 88.22, leaving them 8.3 percent below the 52-week high of USD 96.29 and 21.1 percent above the low of USD 72.30. Volume was 4.25 million shares, above the average volume of 2.88 million shares.